Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Delcath Systems
company
About
Delcath Systems is an interventional oncology company that focuses on the treatment of metastatic liver cancer.
- New York,New York,United States
- 11 - 50
- http://www.delcath.com
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $6.20M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 1987
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Stock Symbol
- fra:DV3P
- Legal Name
- Delcath Systems, Inc.
Delcath Systems is an interventional oncology company that focuses on the treatment of metastatic liver cancer. Its proprietary product Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
11
$149.60M
Delcath Systems has raised a total of
$149.60M
in funding over 2 rounds. Their latest funding was raised on
Dec 8, 2022 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 8, 2022 | Post-IPO Equity | $6.20M | — | — | — | Detail |
| Jul 18, 2022 | Post-IPO Equity | $5M | — | — | — | Detail |
| Aug 9, 2021 | Post-IPO Debt | $20M | 1 |
|
— | Detail |
| Dec 11, 2020 | Post-IPO Equity | $22.20M | — | — | — | Detail |
| Jul 23, 2019 | Post-IPO Equity | $20M | — | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Delcath Systems is funded by 2 investors.
Avenue Capital Group
and Silicon Valley Bank
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Post-IPO Debt |
Silicon Valley Bank
|
Yes | Post-IPO Debt |
Employee Profiles
Number of Employee Profiles
6
Delcath Systems has 6 current employee profiles, including
Employee John Sylvester
Employee
Executive
Executive
Executive
Employee
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
